Allstate (NYSE:ALL) PT Raised to $214.00

Allstate (NYSE:ALLFree Report) had its price objective upped by BMO Capital Markets from $205.00 to $214.00 in a report published on Friday morning, Marketbeat Ratings reports. They currently have an outperform rating on the insurance provider’s stock.

A number of other brokerages also recently commented on ALL. Wells Fargo & Company lowered their target price on Allstate from $177.00 to $175.00 and set an “equal weight” rating on the stock in a research note on Friday, August 16th. The Goldman Sachs Group upped their target price on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research note on Thursday, August 15th. UBS Group upped their target price on Allstate from $215.00 to $216.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. StockNews.com downgraded Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Finally, Bank of America lowered their target price on Allstate from $226.00 to $216.00 and set a “buy” rating on the stock in a research note on Thursday, October 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $206.44.

View Our Latest Research Report on ALL

Allstate Stock Down 1.4 %

Allstate stock opened at $192.64 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36. The business’s 50-day simple moving average is $187.08 and its two-hundred day simple moving average is $173.96. The company has a market cap of $50.84 billion, a PE ratio of 42.53, a PEG ratio of 1.74 and a beta of 0.48. Allstate has a fifty-two week low of $121.70 and a fifty-two week high of $198.79.

Allstate (NYSE:ALLGet Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $0.33 by $1.28. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business had revenue of $15.71 billion for the quarter, compared to the consensus estimate of $14.04 billion. During the same quarter in the previous year, the business earned ($4.42) EPS. The company’s quarterly revenue was up 12.4% compared to the same quarter last year. Equities analysts anticipate that Allstate will post 15.19 EPS for the current year.

Insider Activity at Allstate

In related news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now directly owns 19,163 shares in the company, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Rise Advisors LLC purchased a new position in Allstate in the first quarter valued at $26,000. Northwest Investment Counselors LLC purchased a new position in Allstate in the first quarter valued at $26,000. Versant Capital Management Inc boosted its holdings in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 78 shares during the period. Family Firm Inc. purchased a new position in Allstate in the second quarter valued at $38,000. Finally, MCF Advisors LLC boosted its holdings in Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 84 shares during the period. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Allstate Company Profile

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Read More

Analyst Recommendations for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.